Rimegepant for acute dizziness in migraine-related vertigo
Treatments studied
Part of Brain & nervous system, Ear, nose & throat clinical trials.
This study tests whether a medicine called rimegepant can quickly stop dizziness attacks that are related to migraine. It is for people who have had repeated, moderate-to-severe dizziness spells with migraine-like symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 65 years old.
- Your dizziness is moderate to severe (a score of 4 or more on a 0-10 scale).
- You have had at least 3 dizziness attacks in the past, each lasting more than 2 hours.
- Your dizziness attacks typically come with migraine-like symptoms such as headache, sensitivity to light or sound, nausea, or visual aura.
- You have had basic lab tests and imaging to rule out other causes of dizziness.
- You are not pregnant or breastfeeding, and do not have serious heart, liver, kidney, or mental health conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if rimegepant can help reduce dizziness from vestibular migraine. It is for people who have tried at least one other preventive treatment without success and have frequent dizzy days.
This study tests if the medicine rimegepant is safe for people with migraine. You may be able to join if you have had migraine for at least a year, have 4–14 migraine days per month, and have not had good results with other migraine medicines called triptans.
This study tests whether the medication rimegepant can help prevent chronic migraine in adults. It may be an option if you have frequent migraines and have not tried certain other preventive treatments.
This trial tests whether a medication called rimegepant can prevent migraines when you take it before a known trigger (like exercise or stress). It is for people who get migraines often and can predict when one might happen.
This study tests if the drug rimegepant can help prevent migraine attacks in women. It aims to see how well it works in real life in China.
This trial studies how well a “gepant” medicine works for different types of migraine and how tolerable it is. It may help if you have frequent migraines and you can keep a headache diary as the study asks.
Hear when a new Dizziness trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.